Comprehensive Multispectroscopic and Molecular Docking Investigation of the Anticancer Drug Idarubicin–Bovine Serum Albumin Interaction

Fuente: Wiley Open Access
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mehmetcan Bilkay, Aytekin Gharanjik, Ahmad Fadhlurrahman Ahmad Hidayat, Saharuddin B. Mohamad, Hayriye Eda Satana Kara
Format: Artículo Open Access
Publié: Wiley 2026
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1867015447702929408
author Mehmetcan Bilkay
Aytekin Gharanjik
Ahmad Fadhlurrahman Ahmad Hidayat
Saharuddin B. Mohamad
Hayriye Eda Satana Kara
author_facet Mehmetcan Bilkay
Aytekin Gharanjik
Ahmad Fadhlurrahman Ahmad Hidayat
Saharuddin B. Mohamad
Hayriye Eda Satana Kara
Mehmetcan Bilkay
Aytekin Gharanjik
Ahmad Fadhlurrahman Ahmad Hidayat
Saharuddin B. Mohamad
Hayriye Eda Satana Kara
collection Wiley Open Access
contents Comprehensive Multispectroscopic and Molecular Docking Investigation of the Anticancer Drug Idarubicin–Bovine Serum Albumin Interaction Mehmetcan Bilkay Aytekin Gharanjik Ahmad Fadhlurrahman Ahmad Hidayat Saharuddin B. Mohamad Hayriye Eda Satana Kara Luminescence ABSTRACT Understanding the binding mechanism of idarubicin (IDA), a chemotherapeutic agent used in the treatment of acute myeloid leukemia (AML), with bovine serum albumin (BSA) is essential for elucidating its toxicity and pharmacodynamic and pharmacokinetic behavior and for supporting the development of novel drugs. In this study, the interaction between IDA and BSA was comprehensively investigated using spectroscopic techniques, including steady‐state fluorescence, 3D fluorescence, synchronous fluorescence, competitive displacement assays, UV–Vis absorption spectroscopy, and Fourier transform infrared (FT‐IR) spectroscopy, along with dynamic light scattering (DLS) and molecular docking analysis. The interaction was confirmed by fluorescence and UV–Vis spectra, and the binding constant was determined as K a  = 1.74 × 10 4  M −1 . Fluorescence quenching analysis indicated a predominantly static quenching mechanism, suggesting the formation of a ground‐state complex. Thermodynamic results revealed that hydrogen bonding, hydrophobic interactions, and van der Waals forces play dominant roles in the binding process. Furthermore, 3D and synchronous fluorescence studies demonstrated that IDA alters the polarity of the BSA microenvironment. Molecular docking and displacement studies showed that IDA binds to all three BSA sites, with a significantly higher affinity for Site III compared to Site I and Site II. These findings provide valuable insight into the IDA–BSA interaction mechanism. 10.1002/bio.70513 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/bio.70513
format Artículo Open Access
id wiley_oa_10_1002_bio_70513
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2026
publisher Wiley
record_format wiley_oa
spellingShingle Comprehensive Multispectroscopic and Molecular Docking Investigation of the Anticancer Drug Idarubicin–Bovine Serum Albumin Interaction
Mehmetcan Bilkay
Aytekin Gharanjik
Ahmad Fadhlurrahman Ahmad Hidayat
Saharuddin B. Mohamad
Hayriye Eda Satana Kara
Luminescence
Comprehensive Multispectroscopic and Molecular Docking Investigation of the Anticancer Drug Idarubicin–Bovine Serum Albumin Interaction Mehmetcan Bilkay Aytekin Gharanjik Ahmad Fadhlurrahman Ahmad Hidayat Saharuddin B. Mohamad Hayriye Eda Satana Kara Luminescence ABSTRACT Understanding the binding mechanism of idarubicin (IDA), a chemotherapeutic agent used in the treatment of acute myeloid leukemia (AML), with bovine serum albumin (BSA) is essential for elucidating its toxicity and pharmacodynamic and pharmacokinetic behavior and for supporting the development of novel drugs. In this study, the interaction between IDA and BSA was comprehensively investigated using spectroscopic techniques, including steady‐state fluorescence, 3D fluorescence, synchronous fluorescence, competitive displacement assays, UV–Vis absorption spectroscopy, and Fourier transform infrared (FT‐IR) spectroscopy, along with dynamic light scattering (DLS) and molecular docking analysis. The interaction was confirmed by fluorescence and UV–Vis spectra, and the binding constant was determined as K a  = 1.74 × 10 4  M −1 . Fluorescence quenching analysis indicated a predominantly static quenching mechanism, suggesting the formation of a ground‐state complex. Thermodynamic results revealed that hydrogen bonding, hydrophobic interactions, and van der Waals forces play dominant roles in the binding process. Furthermore, 3D and synchronous fluorescence studies demonstrated that IDA alters the polarity of the BSA microenvironment. Molecular docking and displacement studies showed that IDA binds to all three BSA sites, with a significantly higher affinity for Site III compared to Site I and Site II. These findings provide valuable insight into the IDA–BSA interaction mechanism. 10.1002/bio.70513 http://creativecommons.org/licenses/by/4.0/
title Comprehensive Multispectroscopic and Molecular Docking Investigation of the Anticancer Drug Idarubicin–Bovine Serum Albumin Interaction
topic Luminescence
url https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bio.70513